Quantitative Evaluation of Safety in Drug Development : Design, Analysis and Reporting Hardback
Edited by Qi (Amgen, Inc., Thousand Oaks, California, USA) Jiang, H. Amy (Amgen Inc, Thousand Oaks, California, USA) Xia
Part of the Chapman & Hall/CRC Biostatistics Series series
State-of-the-Art Methods for Drug Safety AssessmentResponding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development.
It presents the latest statistical methods for drug safety assessment.
The book's three sections focus on study design, safety monitoring, and data evaluation/analysis.
The book addresses key challenges across regulatory agencies, industry, and academia.
It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community.
It shares best practices and stimulates further research and methodology development in the drug safety area.
- Format: Hardback
- Pages: 382 pages, 21 color figures in an 16-page insert follows page 172; Approx 86 lines of equations; 26
- Publisher: Taylor & Francis Inc
- Publication Date: 08/12/2014
- Category: Pharmaceutical technology
- ISBN: 9781466555457